Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Prrt Podcasts

show episodes
 
The Neuroendocrine Cancer Foundation Podcast is a monthly series where we interview neuroendocrine cancer experts on various NET topics. Each expert will answer the top 10 FAQs in their area of expertise. Whether a listener is newly diagnosed, a longtime NET survivor, or a family member or loved one, the Neuroendocrine Cancer Foundation Podcast serves as a tool to help anyone better understand neuroendocrine cancer. For more information, visit www.ncf.net/podcast.
  continue reading
 
Podcast of The Journal of Nuclear Medicine (JNM)—a leading medical imaging journal self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). In JNM Podcast, our esteemed editors speak with experts in the field to discuss emerging technologies and rapidly changing issues in practice and research. JNM: https://jnm.snmjournals.org SNMMI: http://www.snmmi.org
  continue reading
 
Loading …
show series
 
Neuroendocrine tumors are rare and can present with a confusing range of symptoms, which leads to frequent misattribution. Jay Bart Rose, M.D., explains how they’re also complex to treat, often requiring multiple modalities based on tumor location and hormone activity. He discusses surgery, systemic therapies, and PRRT, a targeted treatment that us…
  continue reading
 
One of the key aspects of one’s neuroendocrine cancer care is building your medical team, which typically includes a medical oncologist. In this episode, Medical Oncologist Dr. Sandy Kotiah from Mercy Medical Center in Baltimore expounds on the role of a medical oncologist. She sheds light on the first appointment, communication, and care coordinat…
  continue reading
 
Non-muscle invasive bladder cancer is common, recurrent, and often misunderstood. Urologist Jed Ferguson, M.D., and urologic oncologist Chaz Peyton, M.D., explain how it differs from muscle invasive disease, why recurrence increases the risk of progression, and the complex factors that determine treatment sequencing. Learn about UAB’s clinical tria…
  continue reading
 
When in one’s neuroendocrine cancer journey might a clinical trial be considered? What factors influence treatment decisions, including whether to pursue a clinical trial? Dr. Alexandria Phan, medical oncologist at the Medical College of Wisconsin, offers thoughtful guidance on when and how clinical trials fit into the neuroendocrine cancer journey…
  continue reading
 
Radiation therapy for oral cancer requires both precise targeting and multidisciplinary coordination. Christopher Willey, M.D., and Michael Case, D.M.D., explain how close collaboration between radiation oncology and dental care helps prevent complications such as osteoradionecrosis and also minimizes treatment delays. They describe how pretreatmen…
  continue reading
 
ACL tears are on the rise as more people remain active throughout their lives. Amit Momaya, M.D., chief of sports medicine, explains how today’s treatment approaches balance repair and reconstruction, with an emphasis on prehab, rehab, and psychological readiness. Learn about prevention strategies, retear risk factors, and surgical innovations bein…
  continue reading
 
Are airbag vests protecting young equestrians or putting them at risk? Sports medicine physician Sarah Gould, M.D., and engineering research scientist Kevin Schrum discuss unexpected injuries linked to equestrian air vests. They explain how the vests function, why pediatric riders may be especially vulnerable to related injuries, and why stronger d…
  continue reading
 
Kidney stones are often more than a one-time painful event: they’re a chronic disease linked to other health issues. Kyle Wood, M.D., discusses how stone disease often coexists with conditions like hypertension, dietary imbalance, and primary hyperparathyroidism. He explains that reviewing patient history, taking bloodwork, and ordering urine testi…
  continue reading
 
Standardized uptake values (SUV) measure a patient's response to nuclear medicine therapy. But what other markers of success are there, and do these markers and the interpretation of them vary depending on the disease being imaged? Sally Barrington, MD, works specifically on lymphoma and shares her expertise on what markers of success and criteria …
  continue reading
 
For many patients, it takes time to regain full consciousness after a brain injury, and some develop a disorder of consciousness (DOC). Rachel Teranishi, M.D., a brain injury specialist, explains why up to 40% of DOC cases are misdiagnosed and outlines what providers need to know about assessment, treatment, and long-term recovery. Learn which ther…
  continue reading
 
What is Carcinoid Heart Disease (CHD)? Which NET patients develop CHD? Retired cardiologist and carcinoid heart disease specialist Dr. Jerome Zacks provides an overview of CHD and describes the appropriate screening, diagnosis, and treatment. MEET DR. JEROME ZACKS Dr. Jerome Zacks is a Cardiologist/Carcinoid Heart Disease Specialist; retired since …
  continue reading
 
In this special episode, medical oncologist and NET expert Dr. Diane Reidy-Lagunes engages in an open and honest discussion on sensitive topics, including sexual health, family planning and end-of-life discussions. She also answers common questions regarding cannabis use with cancer, as well as the relationship between sugar and cancer. Dr. Reidy s…
  continue reading
 
Limb salvage can prevent amputation in patients with complex lower extremity conditions, including diabetes and peripheral arterial disease. Kyle Mauk, DPM, discusses how UAB’s limb salvage program integrates podiatry with vascular surgery to improve coordination of care. He also explains podiatry’s evolving role in surgical treatment.…
  continue reading
 
Advances in imaging and molecular testing are changing how thyroid diseases are diagnosed and treated. Otolaryngologists and head and neck endocrine surgeons Andrew R. Fuson, M.D., and Daniel J. Rocke, M.D., discuss the latest approaches to managing thyroid nodules, hyperthyroidism, and thyroid cancer. They explain how better risk stratification al…
  continue reading
 
Is PSMA becoming so regularly used that it's...boring? Not according to this lively discussion. Join us for episode 9 of the JNM Podcast, where host Ken Herrmann discusses the state of PSMA PET with experts Thomas Hope, Oliver Sartor, and Wolfgang Fendler. The panel talks about PSMA PET in clinical trials vs. real-life disease management, appropria…
  continue reading
 
Thoracic outlet syndrome (TOS) occurs when blood vessels and nerves in the upper chest become compressed, leading to pain, numbness, swelling, or circulation problems in the arms. Jarrad Rowse, M.D., a vascular surgeon, explains the three types of TOS — neurogenic, venous, and arterial — why they develop, and how they are diagnosed. He discusses mu…
  continue reading
 
Non-tuberculous mycobacterial (NTM) disease is a chronic lung infection that’s becoming more common, yet diagnosis and treatment remain challenging. Infectious disease specialist German Henostroza, M.D., and pulmonologist Bryan Garcia, M.D., discuss what’s known about NTM’s rise; the latest in diagnostic tools; and the complexities of treatment. Le…
  continue reading
 
The JNM Podcast is back in 2025! Join Ken Herrmann, MD, and co-moderator Frank Bengel, MD, for an episode on cardiovascular perfusion imaging. In the U.S., SPECT imaging makes up five to six million studies per year. But PET studies make up just 2.2 million, and only 7%, or 150,000 of those, are cardiac PET imaging. But that may be about to change.…
  continue reading
 
In this special episode, Oregon Health & Sciences University (OHSU) Medical oncologist Dr. Guillaume (Will) Pegna recaps the North American Neuroendocrine Tumor Society (NANETS) 2024 Multidisciplinary NET Medical Symposium. He shares the latest developments in NET research and medical advances from the conference and how they matter to the NET pati…
  continue reading
 
Rehabilitation psychologists help patients with disabilities and chronic health conditions maximize their health and holistic well-being. Casey Azuero, Ph.D., explains these psychologists’ unique qualifications and how they function on interdisciplinary teams to address the full context of a patient’s recovery. This work includes helping patients n…
  continue reading
 
Functional neurological disorder (FND) results in fluctuating control of voluntary activities. Victor Mark, M.D., explains why FND has only recently begun to be acknowledged as a neurological rather than purely psychological disorder. He discusses conditions related to FND and effective rehabilitation coordinated between neurologists, psychologists…
  continue reading
 
What is the best approach to treating substance use disorders? In part two of their discussion on substance use disorders within the health care provider population, Christopher Godlewski, M.D., and Sudheer Potru, D.O., explore the often-complementary effects of medication-assisted therapy and psychotherapeutic approaches. They urge education and e…
  continue reading
 
Just as many health care providers face substance use disorder (SUD) as the general population, yet they are more likely to conceal it due to a professional stigma. Christopher Godlewski, M.D., and Sudheer Potru, D.O., discuss how burnout and demanding work environments contribute to SUD, and how colleagues’ reluctance to intervene can delay help. …
  continue reading
 
ABOUT THIS EPISODE What is radiation oncology, and how is it used for neuroendocrine cancer? UCSF radiation oncologists Dr. Will Chen and Dr. Alexandra Hotca-Cho describe external radiation therapy (SBRT) and how, when, and where it may be used for select patients with neuroendocrine cancers. They address common concerns about the planning process,…
  continue reading
 
Get ready for an episode that's a bit...meta. In Episode 7, our host Ken Herrmann is joined by the podcasters behind GU Cast: Declan Murphy, FRACS, FRCS, and Renu Eapen, MBBS, FRACS. Together with Wolfgang Weber, MD, PhD, they discuss how social media has shaped the landscape of medicine - from how we get medical news, to sharing new research to in…
  continue reading
 
For patients with AFib, left atrial appendage (LAA) occlusion should now be part of any non-emergency cardiac operation, and surgical ablation should also be considered. Panayotis Vardas, M.D., discusses how he and colleagues from the Society of Thoracic Surgeons arrived at stronger recommendations for these procedures in their 2023 guidelines. Lea…
  continue reading
 
Interventional endoscopic ultrasound, once a purely diagnostic tool, has given GI specialists a minimally invasive approach to a wide range of procedures. Ramzi Mulki, M.D., guides us through the evolution of the endoscope since the 1980s; various current uses of interventional endoscopy such as pancreas, gallbladder, bile duct, and bariatric proce…
  continue reading
 
A new type of catheter ablation called pulsed field ablation (PA) allows for a more precise and non-heated way to treat many cases of atrial fibrillation (A-fib). Tom McElderry, M.D., discusses the advantages of PA ablation as an alternative to radio frequency and cryotherapy ablation, the most common types. Dr. McElderry was involved with clinical…
  continue reading
 
ABOUT THIS EPISODE In this 2-part series, Dr. Osman Ahmed from the University of Chicago covers liver-directed therapies for neuroendocrine neoplasms (NENs or neuroendocrine cancer). In this second episode, he details the embolization techniques, including bland embolization (TAE), chemoembolization (TACE), and radioembolization (TARE, SIRT, y90). …
  continue reading
 
Almost everyone with spinal stenosis will see decreased pain and other symptoms following treatment, no matter their age. Thomas Staner, M.D., a neurosurgeon, discusses how improved imaging and a multidisciplinary approach has enhanced care for those with pain and other symptoms caused by spinal stenosis. Learn how treatments can progress from phys…
  continue reading
 
Telehealth coupled with patient-collected data is allowing doctors to manage diabetes more effectively. Anish Patel, M.D., an endocrinologist, discusses how telehealth reduces hospitalizations and readmissions, and allows doctors to personalize treatment plans based on a stream of real-time data. Learn more about how easy it can be for patients to …
  continue reading
 
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a new, more precise name for nonalcoholic fatty liver disease. Fernando Bril, M.D., an endocrinologist, explains how this name precisely describes the way in which fatty acids build up in the liver of patients who have insulin resistance. Learn more about the close relationship of …
  continue reading
 
Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2. NETTER-2 was the first trial to examine radioligand therapy as a first-line therapy for cancers, as opposed to waiting until later stages. Our panelists discuss the results of this trial and its implication…
  continue reading
 
ABOUT THIS EPISODE In this 2-part series, Dr. Osman Ahmed from University of Chicago covers liver-directed therapies for neuroendocrine neoplasms (NENs or neuroendocrine cancer). In this first episode, he outlines the types of liver-directed therapies and elaborates on ablative techniques including the newest technique, histotripsy. Listen to a fra…
  continue reading
 
How is care improving for the three percent of U.S. children who have type 1 diabetes? Jessica Schmitt, M.D., a pediatric endocrinologist, shares encouraging developments in medical diabetes management as well as insights about accurate diagnosis and helpful lifestyle habits. Learn about new treatments on the horizon, including one medication that …
  continue reading
 
The prevalence of peripheral arterial disease (PAD) is surging due to cases related to diabetes. Benjamin Pearce, M.D., a vascular surgeon, discusses management of PAD by highlighting three non-operative advancements, including exercise therapy. Learn how PAD can be diagnosed using an ankle-brachial index. Dr. Pierce explains how a multi-disciplina…
  continue reading
 
85% of all non-melanoma skin cancers occur in the head and neck, which includes high-risk sub-units. Skin cancer is especially prevalent in the South. Harishanker Jayarajan, M.D., a head and neck surgeon, discusses the types and locations of skin lesions which warrant referral to an expert. He explains the general approach to treating head-and-neck…
  continue reading
 
What is supportive care or supportive oncology? What is cancer-related distress? How might NET patients benefit from supportive care? Yale oncologist Dr. Maryam Lustberg suggests strategies to manage cancer-related fatigue, diarrhea, nausea, mouth sores, peripheral neuropathy, distress, anxiety, and anxiety. She also addresses considerations for fe…
  continue reading
 
Patients who have surgery where there is an enhanced recovery program (ERP) recover faster and more effectively. Daniel Chu, M.D., a GI surgeon, discusses the many steps included in an ERP protocol and what it takes to establish the program. He explains how a multidisciplinary team of champions progresses through four phases of implementation. Lear…
  continue reading
 
Radioligand therapy (RLT) targets cancer cells with radiation while minimizing impact on surrounding healthy tissue. In this episode of JNM Podcast, our panelists discuss training, access, production capacity, and everything else that is necessary to make RLT more widely available to the patients who need it. Moderator: Ken Herrmann, MD (Universitä…
  continue reading
 
Pediatric and adolescent gynecology spans the gap between general pediatric care and adult gynecologic care. Janeen Arbuckle, M.D., speaks on her specialty in pediatric and adolescent gynecology, describing first the common conditions that warrant a visit for young women before and during adolescence. She highlights differences between the care gro…
  continue reading
 
Substance use disorder (SUD) is a deadly disease that can affect anyone — even doctors. But certain social determinants of health and psychological trauma make some more vulnerable than others. In part 2 of their discussion on SUD treatment and recovery,Christopher Godlewski, M.D., and Sudheer Potru, D.O., discuss how doctors can account for the pa…
  continue reading
 
ABOUT THIS EPISODE What is immunotherapy? How effective are they for neuroendocrine neoplasms (NENs)? Dr. Jennifer Eads from Penn Medicine answers common questions about immunotherapy. She discusses the latest in CAR T therapy, DLL3, and vaccine therapy for NENs. TOP TEN QUESTIONS ABOUT IMMUNOTHERAPY FOR NENS: What is immunotherapy? How does it wor…
  continue reading
 
Substance use disorder (SUD) is a deadly disease that can affect anyone — even doctors. Christopher Godlewski, M.D., an anesthesiologist, and Sudheer Potru, D.O., an addiction medicine specialist, discuss the barriers to effective treatment of SUDs, both inside and outside of health care. They review the standard pharmacologic and behavioral therap…
  continue reading
 
Behavioral and mental health is part of every serious medical condition. According to Christina Pierpaoli Parker, Ph.D., a licensed clinical psychologist, behavioral medicine belongs closer to patients in primary and specialty care clinics. She explains why many patients are not getting the mental health care they need and how integrated care model…
  continue reading
 
Bone disorders such as osteoporosis are silent diseases that most often affect women. Basma Abdulhadi, M.D., explains the importance of screening women over 65 (as well as those with other risk factors) to identify bone density loss and take steps to prevent dangerous fractures. Learn more about the DEXA scan, which helps doctors establish a patien…
  continue reading
 
What is chemotherapy? When are they used for neuroendocrine neoplasms (NENs)? Dr. Pamela Kunz from Yale Medicine discusses the benefits, potential side effects and latest advances in chemotherapy for NENs. She explains how it differs from other treatments for NENs and how she counsels patients as they consider chemotherapy. TOP TEN QUESTIONS ABOUT …
  continue reading
 
The VISION Trial is the first-in-its-field study to use radiopharmaceuticals that directly target prostate cancer tumors. Hear from one of the lead researchers on this ground-breaking study as he discusses how the trial has opened up a completely new field of study in prostate cancer research and shaped the future of nuclear medicine therapy in com…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play